Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

NCT04134260 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
586
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

NRG Oncology

Collaborators